Neonatal adrenoleukodystrophy digital illustration

Neonatal adrenoleukodystrophy Save


ICD-10 code: E71.511

Disease category: E71.51: Disorders of peroxisome biogenesis

Neonatal adrenoleukodystrophy, or NALD, is a rare genetic disorder that affects the nervous system and adrenal glands. It is a type of leukodystrophy, which means it affects the myelin sheath that surrounds nerves in the brain and spinal cord. NALD is caused by mutations in certain genes that affect the function of peroxisomes, which are organelles in cells that help break down certain fats and other substances. Here are some important facts about NALD:

Symptoms of NALD
  • Delayed development
  • Low muscle tone
  • Seizures
  • Vision and hearing problems
  • Liver dysfunction
  • Adrenal insufficiency

The symptoms of NALD usually appear in the first few months of life, and may be similar to those of other leukodystrophies. Diagnosis is often made through genetic testing, which can identify mutations in the PEX genes associated with NALD.

Treatment of NALD

There is currently no cure for NALD, and treatment is focused on managing symptoms and preventing complications. This may include medications to control seizures, physical and occupational therapy to improve mobility and coordination, and nutritional support to manage liver dysfunction. It is important for individuals with NALD to receive ongoing medical care to monitor their condition and manage any complications that may arise.

Prognosis for NALD

The prognosis for NALD varies depending on the severity of the condition and the age at which symptoms appear. In general, individuals with NALD have a shortened lifespan and may experience progressive neurological deterioration. However, some individuals with milder forms of the condition may have a longer lifespan and less severe symptoms.

Genetic Counseling for NALD

Because NALD is a genetic disorder, it is important for individuals with the condition and their families to receive genetic counseling. This can help them understand the risk of passing the condition on to future generations, and explore options for family planning and prenatal testing.

Overall, NALD is a rare but serious condition that can have significant impacts on individuals and their families. While there is currently no cure, ongoing medical care and support can help manage symptoms and improve quality of life.

Treatment of Neonatal adrenoleukodystrophy:

Neonatal adrenoleukodystrophy (NALD) is a rare genetic disorder that affects the nervous system and adrenal glands. The condition is usually diagnosed in infancy and can cause a range of symptoms, including developmental delays, vision and hearing problems, seizures, and adrenal gland dysfunction. There is currently no cure for NALD, but there are treatment options available to manage the sympt...

To see full information about treatment please Sign up or Log in